Literature DB >> 11159552

Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).

S Kunishima1, T Kojima, T Matsushita, T Tanaka, M Tsurusawa, Y Furukawa, Y Nakamura, T Okamura, N Amemiya, T Nakayama, T Kamiya, H Saito.   

Abstract

Macrothrombocytopenia with leukocyte inclusions is a rare autosomal dominant platelet disorder characterized by a triad of giant platelets, thrombocytopenia, and characteristic Döhle body-like leukocyte inclusions. A previous study mapped a locus for the disease on chromosome 22q12.3-q13.2 by genome-wide linkage analysis. In addition, the complete DNA sequence of human chromosome 22 allowed a positional candidate approach, and results here indicate that the gene encoding nonmuscle myosin heavy chain-A, NMMHC-A, is mutated in this disorder. Mutations were found in 6 of 7 Japanese families studied: 3 missense mutations, a nonsense mutation, and a one-base deletion resulting in a premature termination. Immunofluorescence studies revealed that NMMHC-A distribution in neutrophils appeared to mimic the inclusion bodies. These results provide evidence for the involvement of abnormal NMMHC-A in the formation of leukocyte inclusions and also in platelet morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159552     DOI: 10.1182/blood.v97.4.1147

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Anesthetic management without perioperative platelet transfusion for cervical laminectomy and laminoplasty in a case of May-Hegglin anomaly.

Authors:  Masateru Kumemura; Takeshi Omae; Keito Kou; Sonoko Sakuraba; Naoko Niimi; Shinji Kunishima
Journal:  J Anesth       Date:  2018-06-22       Impact factor: 2.078

3.  Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

Authors:  K E Heath; A Campos-Barros; A Toren; G Rozenfeld-Granot; L E Carlsson; J Savige; J C Denison; M C Gregory; J G White; D F Barker; A Greinacher; C J Epstein; M J Glucksman; J A Martignetti
Journal:  Am J Hum Genet       Date:  2001-10-04       Impact factor: 11.025

4.  Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity.

Authors:  Keri B Sanborn; Emily M Mace; Gregory D Rak; Analisa Difeo; John A Martignetti; Alessandro Pecci; James B Bussel; Rémi Favier; Jordan S Orange
Journal:  Blood       Date:  2011-11-24       Impact factor: 22.113

Review 5.  MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.

Authors:  Alessandro Pecci; Xuefei Ma; Anna Savoia; Robert S Adelstein
Journal:  Gene       Date:  2018-04-19       Impact factor: 3.688

6.  MYH-9 Related Platelet Disorders: Strategies for Management and Diagnosis.

Authors:  Karina Althaus; Andreas Greinacher
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

7.  Temperature dependence of myosin-II tail fragment assembly.

Authors:  Peggy M McMahon; Daniel R Hostetter; Sarah E Rice
Journal:  J Muscle Res Cell Motil       Date:  2008-09-11       Impact factor: 2.698

8.  Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.

Authors:  Koichiro Wasano; Tatsuo Matsunaga; Kaoru Ogawa; Shinji Kunishima
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-04       Impact factor: 2.503

9.  MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.

Authors:  Alessandro Pecci; Catherine Klersy; Paolo Gresele; Kieran J D Lee; Daniela De Rocco; Valeria Bozzi; Giovanna Russo; Paula G Heller; Giuseppe Loffredo; Matthias Ballmaier; Fabrizio Fabris; Eloise Beggiato; Walter H A Kahr; Nuria Pujol-Moix; Helen Platokouki; Christel Van Geet; Patrizia Noris; Preethi Yerram; Cedric Hermans; Bernhard Gerber; Marina Economou; Marco De Groot; Barbara Zieger; Erica De Candia; Vincenzo Fraticelli; Rogier Kersseboom; Giorgina B Piccoli; Stefanie Zimmermann; Tiziana Fierro; Ana C Glembotsky; Fabrizio Vianello; Carlo Zaninetti; Elena Nicchia; Christiane Güthner; Carlo Baronci; Marco Seri; Peter J Knight; Carlo L Balduini; Anna Savoia
Journal:  Hum Mutat       Date:  2013-12-12       Impact factor: 4.878

10.  The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway.

Authors:  Zhao Chen; Olaia Naveiras; Alessandra Balduini; Akiko Mammoto; Mary Anne Conti; Robert S Adelstein; Donald Ingber; George Q Daley; Ramesh A Shivdasani
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.